Open Access

Complementarity-Determining Region 3 (CDR3) of the Heavy Chain Only Antibodies: Therapeutic Perspectives

Lea Talpašová

Lea Talpašová

Laboratory of Biomedical Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in KošiceKošice,
Search for this author on
Sciendo|Google Scholar
Talpašová, Lea
, 
Katarína Bhide

Katarína Bhide

Laboratory of Biomedical Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in KošiceKošice,
Search for this author on
Sciendo|Google Scholar
Bhide, Katarína
, 
Tomáš Maľarik

Tomáš Maľarik

Laboratory of Biomedical Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in KošiceKošice,
Search for this author on
Sciendo|Google Scholar
Maľarik, Tomáš
 and 
Mangesh Bhide

Mangesh Bhide

  • Laboratory of Biomedical Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in KošiceKošice,
  • Institute of Neuroimmunology, Slovak Academy of Sciences v. v. i.Bratislava, Slovakia
Search for this author on
Sciendo|Google Scholar
Bhide, Mangesh
  
Jun 27, 2024
Complementarity-Determining Region 3 (CDR3) of the Heavy Chain Only Antibodies: Therapeutic Perspectives's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Published Online: Jun 27, 2024
Page range: 64 - 71
Received: Apr 04, 2024
Accepted: May 21, 2024
DOI: https://doi.org/10.2478/fv-2024-0019
Keywords
© 2024 Lea Talpašová et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Life Sciences, Molecular Biology, Biotechnology, Microbiology and Virology, Medicine, Veterinary Medicine
Journal RSS Feed